NPFF
Basic information
Region (hg38): 12:53506688-53507484
Links
Phenotypes
GenCC
Source: 
ClinVar
This is a list of variants' phenotypes submitted to 
- not_specified (16 variants)
 - not_provided (2 variants)
 
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NPFF gene is commonly pathogenic or not. These statistics are base on transcript: NM_000003717.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum | 
|---|---|---|---|---|---|---|
| synonymous | 0 | |||||
| missense | 13 | 18 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 13 | 3 | 2 | 
GnomAD
Source: 
| Gene | Type | Bio Type | Transcript | Coding Exons | Length | 
|---|---|---|---|---|---|
| NPFF | protein_coding | protein_coding | ENST00000267017 | 3 | 949 | 
| pLI Probability LOF Intolerant  | pRec Probability LOF Recessive  | Individuals with no LOFs  | Individuals with Homozygous LOFs  | Individuals with Heterozygous LOFs  | Defined | p | 
|---|---|---|---|---|---|---|
| 0.0000365 | 0.221 | 125691 | 0 | 18 | 125709 | 0.0000716 | 
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.461 | 52 | 62.2 | 0.836 | 0.00000341 | 716 | 
| Missense in Polyphen | 16 | 16.577 | 0.96518 | 215 | ||
| Synonymous | 1.86 | 15 | 27.3 | 0.549 | 0.00000145 | 235 | 
| Loss of Function | -0.545 | 6 | 4.72 | 1.27 | 2.02e-7 | 51 | 
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p | 
|---|---|---|
| African & African-American | 0.000873 | 0.000862 | 
| Ashkenazi Jewish | 0.00 | 0.00 | 
| East Asian | 0.00 | 0.00 | 
| Finnish | 0.00 | 0.00 | 
| European (Non-Finnish) | 0.0000361 | 0.0000352 | 
| Middle Eastern | 0.00 | 0.00 | 
| South Asian | 0.00 | 0.00 | 
| Other | 0.00 | 0.00 | 
dbNSFP
Source: 
- Function
 - FUNCTION: Morphine modulating peptides. Have wide-ranging physiologic effects, including the modulation of morphine-induced analgesia, elevation of arterial blood pressure, and increased somatostatin secretion from the pancreas. Neuropeptide FF potentiates and sensitizes ASIC1 and ASIC3 channels. {ECO:0000269|PubMed:11587714}.;
 - Pathway
 - Signaling by GPCR;Signal Transduction;Orexin and neuropeptides FF and QRFP bind to their respective receptors;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (q) signalling events;GPCR downstream signalling 
(Consensus)  
Intolerance Scores
- loftool
 - 0.770
 - rvis_EVS
 - 0.1
 - rvis_percentile_EVS
 - 61.28
 
Haploinsufficiency Scores
- pHI
 - 0.0687
 - hipred
 - N
 - hipred_score
 - 0.123
 - ghis
 - 0.473
 
Essentials
- essential_gene_CRISPR
 - N
 - essential_gene_CRISPR2
 - N
 - essential_gene_gene_trap
 - N
 - gene_indispensability_pred
 - N
 - gene_indispensability_score
 - 0.0284
 
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium | 
| Primary Immunodeficiency | Medium | Medium | Medium | 
| Cancer | Medium | Medium | Medium | 
Mouse Genome Informatics
- Gene name
 - Npff
 - Phenotype
 
Gene ontology
- Biological process
 - acute inflammatory response to antigenic stimulus;regulation of membrane depolarization;G protein-coupled receptor signaling pathway;positive regulation of cytosolic calcium ion concentration;neuropeptide signaling pathway;chemical synaptic transmission;negative regulation of heart rate;regulation of signaling receptor activity;spinal cord development;vasopressin secretion;negative regulation of appetite;response to morphine;positive regulation of blood pressure;negative regulation of insulin secretion;regulation of sensory perception of pain;excitatory postsynaptic potential;maternal process involved in female pregnancy;somatostatin secretion
 - Cellular component
 - extracellular region;extracellular space;dendrite;vesicle;perikaryon;axon terminus;postsynapse
 - Molecular function
 - G protein-coupled receptor binding;signaling receptor binding;neuropeptide hormone activity